High dose subcutaneous Anakinra to treat acute respiratory distress syndrome secondary to cytokine storm syndrome among severely ill COVID-19 patients.
Iglesias-Julián E, López-Veloso M, de-la-Torre-Ferrera N, Barraza-Vengoechea JC, Delgado-López PD, Colazo-Burlato M, Ubeira-Iglesias M, Montero-Baladía M, Lorenzo-Martín A, Minguito-de-la-Iglesia J, García-Muñoz JP, Sanllorente-Sebastián R, Vicente-González B, Alemán-Alemán A, Buzón-Martín L.
Iglesias-Julián E, et al. Among authors: garcia munoz jp.
J Autoimmun. 2020 Dec;115:102537. doi: 10.1016/j.jaut.2020.102537. Epub 2020 Aug 20.
J Autoimmun. 2020.
PMID: 32843231
Free PMC article.